Treatment progress in remission of type 2 diabetes
Journal Title: Chinese Journal of Clinical Research - Year 2025, Vol 38, Issue 4
Abstract
Type 2 diabetes is a reversible disease. The remission of type 2 diabetes is defined as maintaining a glycosylated hemoglobin (HbA1c) level＜6.5% and fasting plasma glucose＜7.0 mmol/L for at least 3 months after discontinuation of glucose-lowering medications. Factors independently associated with diabetes remission include islet autoantibodies, duration of diabetes, body mass index, waist circumference, pancreatic islet function, and baseline HbA1c. Lifestyle interventions, caloric restriction, and weight loss are the primary strategies for inducing and maintaining remission, while pharmacological treatment and metabolic surgery play important roles in achieving remission. The mechanisms of remission primarily involve reducing lipid accumulation, alleviating glucolipotoxicity, and improving insulin resistance and β-cell function.
Authors and Affiliations
ZHANG Mimi, TANG Wei
Keywords
Related Articles
- EP ID EP764819
- DOI 10.13429/j.cnki.cjcr.2025.04.006
- Views 21
- Downloads 0
Research advances on the association of nicotinic acetylcholine receptor-related genes and their polymorphisms with lung cancer
Pulmonary embolism and deep venous thrombosis are collectively referred to as venous thromboembolism, while pulmonary embolism is generally caused by deep venous thrombosis, which has the characteristics of sudden and mo...
Dynamic evolution process of tumor microenvironment in colorectal cancer metastasis
"In the process of colorectal cancer metastasis, the tumor microenvironment interacts with primary tumors, secondary tumors, circulating tumor cells, and disseminated tumor cells. This article introduces its dynamic evol...
Relationship between driver gene mutation status in non-small cell lung cancer and the incidence of venous thromboembolism: a Meta-analysis
Objective：To systematically review the incidence of venous thromboembolism (VTE) in patients with non-small-cell lung cancer (NSCLC) by different driver gene mutations, and to further explore the associations of driver...
Progress on the impact of lipid metabolism reprogramming on resistance to epidermal growth factor receptor tyrosine kinase inhibitors in nonsmall cell lung cancer
Non-small cell lung cancer (NSCLC) is the main type of lung cancer, accounting for 85% to 90% of cases. The use of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) has greatly improved the prognosi...
Research progress and treatment status of non-ischemic cardiomyopathy
Cardiomyopathy is a heart disease clinically characterized by enlargement of the heart, arrhythmia and heart failure alone or simultaneously. Ischemic cardiomyopathy is usually caused by coronary atherosclerotic lesions,...